Clinical trial
Molecular and Genetic Studies of Congenital Myopathies
NCT00272883 · Boston Children's Hospital, Other · Recruiting
Key facts
| NCT number | NCT00272883 |
|---|---|
| Title | Molecular and Genetic Studies of Congenital Myopathies |
| Official title | Molecular Analysis of Neuromuscular Disease |
| Lead sponsor | Boston Children's Hospital, Other |
| Collaborators | Muscular Dystrophy Association |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Central Core Disease, Centronuclear Myopathy, Congenital Fiber Type Disproportion, Multiminicore Disease, Myotubular Myopathy, Nemaline Myopathy, Rigid Spine Muscular Dystrophy, Undefined Congenital Myopathy |
| Enrollment | 4,000 |
| Start date | Aug 1, 2003 |
| Primary completion | Jan 1, 2050 |
| Completion | Jan 1, 2050 |
| First posted | Jan 9, 2006 |
| Last update posted | Jun 18, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: